Does Topical Corticosteroids Treat Vitiligo?

Vitiligo causes areas of skin to lose pigment when pigment-producing cells are damaged or no longer active. A topical corticosteroid can reduce local immune activity, which may allow pigment to return in some areas. Repigmentation is often gradual and may differ between body regions; the face can respond differently from hands and feet.

The medicine is not suitable for every person or every patch. Stronger steroids and use on thin skin need particular caution because prolonged exposure can cause thinning, visible small blood vessels, or other changes. The condition can also remain active or develop new patches despite treatment.

A dermatologist can choose the strength, schedule, and treatment area, then review the skin for benefit and irritation. Apply only the directed amount and do not extend treatment to unaffected skin. Protect depigmented areas from sun because they burn more easily; sunscreen and covering clothing can also make colour contrast less noticeable.

Take photographs in consistent lighting if your clinician recommends tracking changes. Do not stop or restart a prescribed course based only on day-to-day colour changes; follow the review plan.

Contact your clinician if treated skin becomes very thin, painful, unusually fragile, or develops persistent redness or prominent vessels. Seek prompt advice for rapid spread of depigmentation, eye symptoms, or major emotional distress related to visible changes, so your care plan can be reconsidered.

Ask whether your patches are active, which areas are suitable for a corticosteroid, when improvement might be assessed, and what other options exist if pigment does not return. Ask how to protect the affected skin from sun and how to recognise steroid irritation.